-
81por Ardalan, Mohammadreza, Moslemi, Hamidreza, Shafiei, Shervin, Tabrizi, Reza, Moselmi, Mohammadreza“…Recurrent herpes simplex virus or varicella zoster virus infection should be considered as one of the rare complications after AstraZeneca vaccination for COVID‐19.…”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
82por Gordon, Sally F., Clothier, Hazel J., Morgan, Hannah, Buttery, Jim P., Phuong, Linny K., Monagle, Paul, Chunilal, Sanjeev, Wood, Erica M., Tran, Huyen, Szer, Jeff, Crawford, Nigel W.“…Twenty-one confirmed or probable cases of ITP were identified following receipt of AstraZeneca (n = 17) or Pfizer-BioNTech (n = 4) vaccines. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
83
-
84“…On March 11, 2021, the AstraZeneca vaccine against COVID-19 was suspended in three Nordic countries and, on subsequent days, in other European countries. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
85“…We report three cases of AstraZeneca vaccine (AZV)-induced radiation recall phenomenon (RRP) in three women who had previously undergone radiotherapy for breast cancer. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
86“…Material and Methods: We reviewed the files of patients with otological symptoms after exposure to the Astra Zeneca COVID-19 vaccine during the year 2021. Case Series: We studied a total of six cases with otologic symptoms temporally related to the Astra Zeneca COVID-19 vaccine. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
87Myocarditis following AstraZeneca (an adenovirus vector vaccine) COVID‐19 vaccination: A case report“…We are unable to confirm a direct association between myocarditis and AstraZeneca vaccination. However, we would like to increase awareness regarding the possibility of developing myocarditis following AstraZeneca vaccination.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
88por Bazrafshan, Hanieh, Mohamadi Jahromi, Leila Sadat, Parvin, Reyhaneh, Ashraf, Alireza“…Herein, we present a 68-year-old woman with paresthesia of both hands associated with gait instability, which started three to four days after receiving the second dose of Oxford/AstraZeneca vaccine against the COVID-19 infection. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
89“…Background: In May 2021, there was an incident regarding giving patients AstraZeneca vaccines stored improperly. They were stored at room temperature (21 degrees centigrade) for 18 h, 12 h longer than the producer recommends. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
90por Ruiz-Núñez, Carlos, Herrera-Peco, Ivan, Campos-Soler, Silvia María, Carmona-Pestaña, Álvaro, Benítez de Gracia, Elvira, Peña Deudero, Juan José, García-Notario, Andrés Ignacio“…The debate was fueled by the adverse effects following the administration of the AstraZeneca-Oxford (AZ) vaccine in some European countries, eventually leading to its temporary suspension as a precautionary measure. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
91“…CASE PRESENTATION: We discuss a 54-year-old female Sri Lankan patient who developed Kounis syndrome following Oxford AstraZeneca COVID-19 vaccination. The patient initially developed anaphylaxis following the AstraZeneca COVID-19 vaccine and subsequently developed acute coronary syndrome secondary to anaphylaxis. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
92“…In this paper, we present a case of ITP relapse in a 31‐year‐old Iranian woman as a potential complication of the AstraZeneca vaccine.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
93Impact of SARS-CoV-2 AstraZeneca Vaccine on Safety and Blood Elements of Egyptian Healthcare Workerspor Meshref, Taghreed S., Hamad, Dina A., Aly, Mai M., Kamal, Dalia T., Elkhayat, Mariam R., Elghazally, Shimaa A.“…Their safety was the primary concern. In Egypt, Oxford–AstraZeneca (AZ) vaccine was the first approved vaccine initially for healthcare workers (HCWs). …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
94
-
95
-
96
-
97
-
98por Mayfield, Helen J., Lau, Colleen L., Sinclair, Jane E., Brown, Samuel J., Baird, Andrew, Litt, John, Vuorinen, Aapeli, Short, Kirsty R., Waller, Michael, Mengersen, Kerrie“…Uncertainty surrounding the risk of developing and dying from Thrombosis and Thrombocytopenia Syndrome (TTS) associated with the AstraZeneca (AZ) COVID-19 vaccine may contribute to vaccine hesitancy. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
99por Marsukjai, Apichai, Theerasuwipakorn, Nonthikorn, Tumkosit, Monravee, Chattranukulchai, Pairoj, Srichomkwun, Panudda, Prechawat, Somchai“…CASE PRESENTATION: A 55-year-old Thai woman presented with palpitation without neck pain 14 days after receiving AstraZeneca coronavirus disease 2019 vaccination. Electrocardiography revealed sinus tachycardia. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
100por Dal-Ré, Rafael“…The deficiently designed and conducted initial clinical development plan and the occurrence of thrombotic thrombocytopenia cases, have marked the first 12-month journey of the AstraZeneca coronavirus disease 2019 (COVID-19) vaccine after it was first administered to humans. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto